表纸
市场调查报告书

Millennium Pharmaceuticals, Inc. - 产品平台分析

Millennium Pharmaceuticals Inc - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品编码 251690
出版日期 内容资讯 英文 61 Pages
订单完成后即时交付
价格
Back to Top
Millennium Pharmaceuticals, Inc. - 产品平台分析 Millennium Pharmaceuticals Inc - Product Pipeline Review - 2016
出版日期: 2016年12月30日内容资讯: 英文 61 Pages
简介

Millennium Pharmaceuticals, Inc.是负责癌症治疗药的研究开发及商品化的生物制药公司。主要产品Velcade (bortezomib) 是为了治疗多发性骨髓瘤和复发性被套细胞淋巴瘤所开发的。该公司产品有15种以上以各种类型癌症为标的的肿瘤临床实验化合物。

本报告提供Millennium Pharmaceuticals, Inc.的治疗药开发平台现状及各开发阶段比较分析,汇整药物标的,作用机制,给药途径,各分子类型的治疗药评估,最新的企业新闻和发表,后期阶段及中止的计划等相关资讯。

Millennium Pharmaceuticals, Inc.的基本资料

Millennium Pharmaceuticals, Inc.概要

  • 主要资讯
  • 企业资料

Millennium Pharmaceuticals, Inc.:R&D概要

  • 主要的治疗范围

Millennium Pharmaceuticals, Inc.:开发平台的检讨

  • 各开发阶段的开发中产品
  • 单剂产品
  • 合作伙伴产品
    • 合作伙伴产品/联合治疗模式
  • 转出授权产品
    • 转出授权产品/联合治疗模式

Millennium Pharmaceuticals, Inc.:开发中产品概况

Millennium Pharmaceuticals, Inc.

  • 最后阶段的开发中产品
    • 登记前的产品/联合治疗模式
    • 申请但不受理/被撤消的产品/联合治疗模式
    • 第三阶段的产品/联合治疗模式
  • 临床实验阶段的开发中产品
    • 第二阶段的产品/联合治疗模式
    • 第一阶段的产品/联合治疗模式
  • 初期阶段产品开发中产品
    • 前临床阶段的产品/联合治疗模式
    • 药物研发中的产品/联合治疗模式

Millennium Pharmaceuticals, Inc.:药物简介

  • bortezomib
  • alisertib
  • brentuximab vedotin
  • ixazomib citrate
  • MLN-0128
  • MLN-2480
  • orteronel
  • MLN-0264
  • MLN-1117
  • MLN-7243
  • pevonedistat hydrochloride
  • TAK-659
  • TAK-733
  • Small Molecules to Inhibit Histone Deacetylase 6 for Cacner

Millennium Pharmaceuticals, Inc.:开发平台分析

  • 标的别
  • 各给药途径
  • 各分子类型
  • 各作用机制

Millennium Pharmaceuticals, Inc.:最近的开发平台趋势

Millennium Pharmaceuticals, Inc.:暂停中的计划

Millennium Pharmaceuticals, Inc.:中止开发的开发中产品

  • 中止开发的开发中产品简介
    • alisertib
    • betrixaban
    • bortezomib
    • HuL-2G7
    • orteronel
    • TAK-441
    • TAK-448
    • TAK-901
    • TAK-960
    • tandutinib

Millennium Pharmaceuticals, Inc.:企业发表

Millennium Pharmaceuticals, Inc.:总公司和子公司的所地

附录

图表

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GMDHC08196CDB

Summary:

Global Markets Direct's, 'Millennium Pharmaceuticals Inc - Product Pipeline Review - 2016', provides an overview of the Millennium Pharmaceuticals Inc's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Millennium Pharmaceuticals Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

  • The report provides a snapshot of the pipeline therapeutic landscape of Millennium Pharmaceuticals Inc
  • The report provides overview of Millennium Pharmaceuticals Inc including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Millennium Pharmaceuticals Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Millennium Pharmaceuticals Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy:

  • Evaluate Millennium Pharmaceuticals Inc's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Millennium Pharmaceuticals Inc
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Millennium Pharmaceuticals Inc's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Millennium Pharmaceuticals Inc Snapshot
    • Millennium Pharmaceuticals Inc Overview
    • Key Facts
  • Millennium Pharmaceuticals Inc - Research and Development Overview
    • Key Therapeutic Areas
  • Millennium Pharmaceuticals Inc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Millennium Pharmaceuticals Inc - Pipeline Products Glance
    • Millennium Pharmaceuticals Inc - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Millennium Pharmaceuticals Inc - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Millennium Pharmaceuticals Inc - Drug Profiles
    • alisertib - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • bortezomib - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • orteronel - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • pevonedistat hydrochloride - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • sapanisertib - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • serabelisib - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit Histone Deacetylase 6 for Oncology - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • TAK-243 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • TAK-580 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • TAK-659 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • TAK-931 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Millennium Pharmaceuticals Inc - Pipeline Analysis
    • Millennium Pharmaceuticals Inc - Pipeline Products by Target
    • Millennium Pharmaceuticals Inc - Pipeline Products by Route of Administration
    • Millennium Pharmaceuticals Inc - Pipeline Products by Molecule Type
    • Millennium Pharmaceuticals Inc - Pipeline Products by Mechanism of Action
  • Millennium Pharmaceuticals Inc - Dormant Projects
  • Millennium Pharmaceuticals Inc - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • alisertib
      • betrixaban
      • bortezomib
      • HuL-2G7
      • indusatumab vedotin
      • IPI-443
      • orteronel
      • TAK-441
      • TAK-733
      • TAK-901
      • TAK-960
      • tandutinib
  • Millennium Pharmaceuticals Inc - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Millennium Pharmaceuticals Inc, Key Facts
  • Millennium Pharmaceuticals Inc - Pipeline by Indication, 2016
  • Millennium Pharmaceuticals Inc - Pipeline by Stage of Development, 2016
  • Millennium Pharmaceuticals Inc - Monotherapy Products in Pipeline, 2016
  • Millennium Pharmaceuticals Inc - Out-Licensed Products in Pipeline, 2016
  • Millennium Pharmaceuticals Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016
  • Millennium Pharmaceuticals Inc - Phase II, 2016
  • Millennium Pharmaceuticals Inc - Phase I, 2016
  • Millennium Pharmaceuticals Inc - Preclinical, 2016
  • Millennium Pharmaceuticals Inc - Discovery, 2016
  • Millennium Pharmaceuticals Inc - Pipeline by Target, 2016
  • Millennium Pharmaceuticals Inc - Pipeline by Route of Administration, 2016
  • Millennium Pharmaceuticals Inc - Pipeline by Molecule Type, 2016
  • Millennium Pharmaceuticals Inc - Pipeline Products by Mechanism of Action, 2016
  • Millennium Pharmaceuticals Inc - Dormant Developmental Projects,2016
  • Millennium Pharmaceuticals Inc - Discontinued Pipeline Products, 2016

List of Figures

  • Millennium Pharmaceuticals Inc - Pipeline by Top 10 Indication, 2016
  • Millennium Pharmaceuticals Inc - Pipeline by Stage of Development, 2016
  • Millennium Pharmaceuticals Inc - Monotherapy Products in Pipeline, 2016
  • Millennium Pharmaceuticals Inc - Out-Licensed Products in Pipeline, 2016
  • Millennium Pharmaceuticals Inc - Pipeline by Top 10 Target, 2016
  • Millennium Pharmaceuticals Inc - Pipeline by Route of Administration, 2016
  • Millennium Pharmaceuticals Inc - Pipeline by Molecule Type, 2016
  • Millennium Pharmaceuticals Inc - Pipeline Products by Top 10 Mechanism of Action, 2016
Back to Top